These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25151851)

  • 1. Identifying the features of an easy-to-use and intuitive dry powder inhaler for asthma and chronic obstructive pulmonary disease therapy: results from a 28-day device handling study, and an airflow resistance study.
    Virchow JC; Weuthen T; Harmer QJ; Jones S
    Expert Opin Drug Deliv; 2014 Dec; 11(12):1849-57. PubMed ID: 25151851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler.
    Prime D; de Backer W; Hamilton M; Cahn A; Preece A; Kelleher D; Baines A; Moore A; Brealey N; Moynihan J
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):486-97. PubMed ID: 26372467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chinese expert consensus on standardized inhaler device application in stable chronic airway diseases (2023)].
    Inhalation Therapy and Respiratory Rehabilitation Group, Respiratory Equipment Committee of China Association of Medical Equipment
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Nov; 46(11):1055-1067. PubMed ID: 37914418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
    Brocklebank D; Ram F; Wright J; Barry P; Cates C; Davies L; Douglas G; Muers M; Smith D; White J
    Health Technol Assess; 2001; 5(26):1-149. PubMed ID: 11701099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-time handling of different inhalers by chronic obstructive lung disease patients.
    Harb HS; Laz NI; Rabea H; Abdelrahim MEA
    Exp Lung Res; 2020 Sep; 46(7):258-269. PubMed ID: 32614625
    [No Abstract]   [Full Text] [Related]  

  • 6. Usage and usability of one dry powder inhaler compared to other inhalers at therapy start: an open, non-interventional observational study in Poland and Germany.
    Hantulik P; Wittig K; Henschel Y; Ochse J; Vahteristo M; Rytila P
    Pneumonol Alergol Pol; 2015; 83(5):365-77. PubMed ID: 26378998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ELLIPTA® Dry Powder Inhaler: Design, Functionality, In Vitro Dosing Performance and Critical Task Compliance by Patients and Caregivers.
    Grant AC; Walker R; Hamilton M; Garrill K
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):474-85. PubMed ID: 26372466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD.
    Svedsater H; Dale P; Garrill K; Walker R; Woepse MW
    BMC Pulm Med; 2013 Dec; 13():72. PubMed ID: 24314123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correct use and ease of use of a placebo dry powder inhaler in subjects with asthma and chronic obstructive pulmonary disease.
    Feldman GJ; Galkin DV; Patel P; Collison KA; Sharma R
    Chron Respir Dis; 2019; 16():1479973118815692. PubMed ID: 30789018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evAluatIon foR inhalation devices in Greek patients with COPD and asthma: The PAIR study.
    Karampitsakos T; Hillas G; Zervas E; Bakakos P; Stratakos G; Dimakou K; Manali E; Bouros D; Papiris S; Tzouvelekis A;
    Pulm Pharmacol Ther; 2020 Feb; 60():101882. PubMed ID: 31881275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A narrative review on the Synchrobreathe™: A novel breath-actuated pressurised metered-dose inhaler for the treatment of obstructive airway diseases.
    Lavorini F; Usmani OS; Salvi S; Rote K; Gaur V; Gogtay J
    Respir Med; 2023; 219():107435. PubMed ID: 38652077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative analysis of errors in inhaler technique among COPD versus asthma patients.
    Ocakli B; Ozmen I; Tunçay EA; Gungor S; Altinoz H; Adiguzel N; Sak ZA; Gungor G; Karakurt Z; Arbak P
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2941-2947. PubMed ID: 30288037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of satisfaction with different dry powder inhalation devices in Greek patients with COPD and asthma: the ANASA study.
    Zervas E; Samitas K; Gaga M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1845-55. PubMed ID: 27540287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novolizer: how does it fit into inhalation therapy?
    Magnussen H
    Curr Med Res Opin; 2005; 21 Suppl 4():S39-46; discussion S47. PubMed ID: 16138944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD.
    Lavorini F; Magnan A; Dubus JC; Voshaar T; Corbetta L; Broeders M; Dekhuijzen R; Sanchis J; Viejo JL; Barnes P; Corrigan C; Levy M; Crompton GK
    Respir Med; 2008 Apr; 102(4):593-604. PubMed ID: 18083019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Device-handling study of a novel breath-actuated inhaler, Synchrobreathe®, versus a pMDI.
    Balamurugan S; Apte K; Singh BP; Deb AK; Deshmukh C; Modi K; Godse A; Dhar R; Lahiri KR; Singh V; Pandya H; Rajan S; Vaidya A; Gaur V; Gogtay J
    Respir Med; 2020 Jan; 161():105707. PubMed ID: 32056719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial.
    Altman P; Wehbe L; Dederichs J; Guerin T; Ament B; Moronta MC; Pino AV; Goyal P
    BMC Pulm Med; 2018 Jun; 18(1):100. PubMed ID: 29898702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient preferences for dry powder inhaler attributes in asthma and chronic obstructive pulmonary disease in France: a discrete choice experiment.
    Hawken N; Torvinen S; Neine ME; Amri I; Toumi M; Aballéa S; Plich A; Roche N
    BMC Pulm Med; 2017 Jul; 17(1):99. PubMed ID: 28683805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How many instructions are required to correct inhalation errors in patients with asthma and chronic obstructive pulmonary disease?
    Takaku Y; Kurashima K; Ohta C; Ishiguro T; Kagiyama N; Yanagisawa T; Takayanagi N
    Respir Med; 2017 Feb; 123():110-115. PubMed ID: 28137486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical relevance of dry powder inhaler performance for drug delivery.
    Demoly P; Hagedoorn P; de Boer AH; Frijlink HW
    Respir Med; 2014 Aug; 108(8):1195-203. PubMed ID: 24929253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.